Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption
What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc….
Continue Reading